Colleen F. Reitan, Director at MYRIAD GENETICS INC (MYGN), sold 92,024 shares at $27.95 ($2.6M) on 2024-09-03, disclosed to the SEC on 2024-09-04.
Scheduled sale ($2.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.95 | 46,012 | $1.3M | 50.0% |
| 2 | $27.95 | 46,012 | $1.3M | 50.0% |
| Total | $27.95 avg | 92,024 | $2.6M | 100% |
| Filing → |
| ALNY | SELL | 2025-05-12 | $8K | — | Filing → |